Fabio
5.0 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Active Pharmaceutical Ingredient Manufacturing Grant Fund; established. | Active Pharmaceutical Ingredient Manufacturing Grant Fund. Establishes the Active Pharmaceutical Ingredient Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $15 million per fiscal year and in an aggregate amount not to exceed $130 million, to a qualified company that (i) engages in the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $2,148,793,019 and create and maintain at least 468 new full-time jobs. This bill is identical to HB 800. | us/states/va | Virginia General Assembly | 2026 | SB 404 | Virginia SB 404 (2026) |
|
enacted |
|
2 | 27 | 5 | 2026-01-13 | 2026-04-13 | openstates | ocd-bill/252d9804-550b-49fc-8067-8da5ea2d0c06 | https://lis.virginia.gov/bill-details/20261/SB404 | 77d283b789675da8bd572deca58baa24c765c304abf4f0fc7f8583a592738946 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 404 (2026) — Active Pharmaceutical Ingredient Manufacturing Grant Fund; established.
Active Pharmaceutical Ingredient Manufacturing Grant Fund. Establishes the Active Pharmaceutical Ingredient Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $15 million per fiscal year and in an aggregate amount not to exceed $130 million, to a qualified company that (i) engages in the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $2,148,793,019 and create and maintain at least 468 new full-time jobs. This bill is identical to HB 800.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
Votes
- Constitutional reading dispensed R — 40–0 (pass) · upper
- Passage R — 38–0 (pass) · upper
- Reported from Finance and Appropriations — 14–0 (pass) · upper
- H VOTE: — 97–0 (pass) · lower
- Reported from Appropriations — 22–0 (pass) · lower
Sponsors
- L. Louise Lucas — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2026-01-13 Prefiled and ordered printed; Offered 01-14-2026 26102909D
filing, introduction - 2026-01-13 Referred to Committee on Finance and Appropriations
referral-committee - 2026-01-23 Fiscal Impact Statement from Department of Planning and Budget (SB404)
- 2026-01-27 Reported from Finance and Appropriations (14-Y 0-N)
committee-passage - 2026-01-28 Rules suspended
- 2026-01-28 Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)
- 2026-01-28 Passed by for the day Block Vote (Voice Vote)
- 2026-01-28 Passed by for the day
- 2026-01-29 Read second time
reading-2 - 2026-01-29 Engrossed by Senate (Voice Vote)
- 2026-01-30 Read third time and passed Senate (38-Y 0-N 0-A)
passage, reading-3 - 2026-02-04 Placed on Calendar
- 2026-02-04 Read first time
reading-1 - 2026-02-04 Referred to Committee on Appropriations
referral-committee - 2026-02-18 Assigned HAPP sub: Commerce Agriculture & Natural Resources
referral-committee - 2026-02-20 Reported from Appropriations (22-Y 0-N)
committee-passage - 2026-02-24 Read second time
reading-2 - 2026-02-25 Read third time
reading-3 - 2026-02-25 Passed House (97-Y 0-N 0-A)
passage - 2026-02-27 Enrolled
enrolled - 2026-02-27 Bill text as passed Senate and House (SB404ER)
passage - 2026-02-27 Fiscal Impact Statement from Department of Planning and Budget (SB404)
- 2026-02-27 Signed by Speaker
passage - 2026-02-27 Signed by President
passage - 2026-03-10 Enrolled Bill communicated to Governor on March 10, 2026
enrolled, executive-receipt - 2026-03-10 Governor's Action Deadline 11:59 p.m., April 13, 2026
executive-receipt - 2026-04-13 Approved by Governor-Chapter 822 (effective 7/1/2026)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/252d9804-550b-49fc-8067-8da5ea2d0c06. Confidence: reported (aggregated from official Virginia legislature records).